PS Ratio:
N/ASummary
- CDTX price to sales ratio is not available.
Performance
CDTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CDTX PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | - | +0.2% | +0.2% | -100.0% |
| 1M1 Month | - | +14.1% | +14.1% | - |
| 3M3 Months | - | +72.5% | +88.3% | -100.0% |
| 6M6 Months | - | +423.1% | +957.1% | - |
| YTDYTD | - | +306.4% | +841.4% | - |
| 1Y1 Year | - | +740.3% | +2924.0% | -100.0% |
| 5Y5 Years | - | +109.3% | +2315.6% | -100.0% |
CDTX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | ||||
| 3M | 3-Month | ||||
| 6M | 6-Month | 3621.57 | 800.09 | ||
| 1Y | 1-Year | 3621.57 | 22.73 | ||
| 3Y | 3-Year | 3621.57 | 0.56 | ||
| 5Y | 5-Year | 3621.57 | 0.54 | ||
| All-Time | All-Time | 3621.57 | 0.54 |
CDTX PS Ratio History
| Date | Value |
|---|---|
| 2024 | 230.78(>+9900.0%) |
| 2023 | 1.67(+96.5%) |
| 2022 | 0.85(-51.1%) |
| Date | Value |
|---|---|
| 2021 | 1.74(-76.6%) |
| 2020 | 7.44(+19.8%) |
| 2019 | 6.21 |
FAQ
- What is the all-time high PS ratio for Cidara Therapeutics, Inc.?
What is the all-time high PS ratio for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high price to sales ratio is 3621.57